Shiran Shapira

Title: Shiran Shapira: Innovator in Cancer Diagnosis and Therapy

Introduction

Shiran Shapira, an accomplished inventor based in Petach-Tikva, Israel, has made significant contributions to the field of medical research, particularly in cancer diagnostics and therapy. With a portfolio of four patents to his name, Shapira's work has the potential to impact patient care and treatment outcomes immensely.

Latest Patents

One of Shapira's latest patents is titled "Cell-derived particles presenting heterologous CD24 and use thereof in therapy." This patent revolves around a method for producing cell-derived particles that are isolated from a biological sample. The method ensures that the preparation is substantially devoid of intact cells, resulting in a unique therapeutic application.

Another significant patent is focused on a "Combination of markers for diagnosing cancer." This method involves determining the expression level of CD24 on leukocytes within a biological sample. A specific threshold level of CD24 on small leukocytes, in contrast to large leukocytes, is indicative of cancer or pre-malignant lesions. Additionally, this patent includes a method for monitoring the efficacy of cancer therapy, along with a diagnostic kit for cancer detection.

Career Highlights

Shapira has worked with esteemed organizations such as the Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center and Ichilov Tech Ltd. His experience at these institutions has provided him with a platform to develop innovative solutions in healthcare.

Collaborations

Throughout his career, Shiran Shapira has collaborated with notable professionals, including Nadir Arber and Dina Kazanov, contributing to a multidisciplinary approach to cancer research and therapy. These collaborations emphasize the importance of teamwork in advancing medical innovations.

Conclusion

Shiran Shapira stands as a prominent figure in the realm of medical innovations, with his patents offering valuable insights and solutions in cancer diagnosis and therapy. His dedication to research and development continues to pave the way for improved patient outcomes and demonstrates the profound impact of innovation in healthcare.